Physician profile
Dooho B Kim
NPI 1992844864
$1,975.21
in general payments reported to CMS, 2019-2025
18 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.51 · 2020: $31.49 · 2021: $344 · 2022: $319 · 2023: $297 · 2024: $628 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $653.74 | 2021-2025 | Veritas Vision System, Tecnis Iol, Tecnis Simplicity |
| Alcon Vision LLC | $368.11 | 2019-2025 | Rocklatan, Clareon, Centurion |
| Shockwave Medical, INC | $174.90 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Tarsus Pharmaceuticals, INC. | $142.19 | 2024 | Xdemvy |
| Allergan, INC. | $134.77 | 2020-2022 | |
| Genentech USA, INC. | $121.11 | 2023-2025 | Vabysmo |
| Abbvie INC. | $78.48 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $74.65 | 2023-2024 | Envista Mx60 Iol, Envista Aspire Toric, Stellaris |
| Oyster Point Pharma, INC. | $58.60 | 2022-2025 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $30.13 | 2022 | |
| Ivantis, INC | $24.22 | 2021 | |
| Amgen INC. | $22.81 | 2024 | Tepezza |
| Sun Pharmaceutical Industries INC. | $22.16 | 2021 | |
| Astellas Pharma US INC | $16.97 | 2025 | Izervay |
| Dompe US, INC. | $14.35 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $13.86 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $12.25 | 2022 | |
| Iridex Corporation | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dooho Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.